WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Pilot Trial of External Warming in Septic Patients
Not Applicable
Completed
- Conditions
- Sepsis
- Interventions
- Other: External warming
- First Posted Date
- 2016-03-11
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT02706275
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)
Phase 2
Withdrawn
- Conditions
- Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
- Interventions
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT02705339
CD36 and Human Fat Taste Perception
Completed
- Conditions
- Obesity
- Interventions
- Other: No intervention
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2016-03-04
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 97
- Registration Number
- NCT02699567
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
Phase 4
Completed
- Conditions
- RhinosinusitisChronic Eosinophilic RhinosinusitisAllergic Rhinosinusitis
- Interventions
- Drug: Saline alone
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2019-09-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT02696850
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Phase 2
Withdrawn
- Conditions
- GliomaRhabdomyosarcomaOsteosarcomaMedulloblastomaNeuroectodermal TumorEpendymomaEwing's SarcomaWilms Tumor
- Interventions
- Biological: Erlotinib
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT02689336
Pneumonia in the Intensive Care Unit (ICU) Setting
Completed
- Conditions
- Respiratory FailurePneumonia
- Interventions
- Behavioral: Antibiotic de-escalation by ICU stewardship team with decreased exposure to broad spectrum antibiotics and shorter duration of therapy
- First Posted Date
- 2016-02-19
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 364
- Registration Number
- NCT02685930
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS
Completed
- Conditions
- C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2016-02-19
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 128
- Registration Number
- NCT02686268
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇳🇱UMC Utrecht, Utrecht, Netherlands
🇺🇸University of Massachusetts, Amherst, Massachusetts, United States
DHEA in Synovial Sarcoma Patients
Phase 1
Terminated
- Conditions
- Synovial SarcomaSarcoma, Synovial
- Interventions
- Other: FACT-67 validated survey
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT02683148
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Epidural Analgesia Use in Pancreatic Resections
Phase 1
Completed
- Conditions
- Pancreas CancerPancreas NeoplasmsCancer of PancreasPancreatic CancerCancer of the Pancreas
- Interventions
- First Posted Date
- 2016-02-12
- Last Posted Date
- 2020-03-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 23
- Registration Number
- NCT02681796
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
Phase 1
Terminated
- Conditions
- Sickle Cell Disease
- Interventions
- Radiation: Total body irradiationProcedure: Hematopoietic stem cell transplant
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT02678143
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath